A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis
Conditions
MF,PMF,PPV-MF,PET-MF
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
West China Hospital Sichuan University, Chengdu, Sichuan, China
Hematology Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality, China
Study leads
Zhijian Xiao, Doctor
Principal Investigator
Hematology Hospital, Chinese Academy of Medical Sciences
Ting Niu, Doctor
Principal Investigator
West China Hospital